Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.49 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8843411 | 0.82 | ALDH1A1 (0.59) | L3MBTL1SMN1; SMN2LMNAHDAC3RAB9A | |
| SCHEMBL12615941 | 0.81 | ALDH1A1 (0.54) | CYP2C19SMN1; SMN2LMNACYP1A2PTGS2 | |
| SCHEMBL3824791 | 0.81 | HDAC3 (0.62) | L3MBTL1SMN1; SMN2HDAC3RAB9ANPC1 | |
| SCHEMBL8843180 | 0.80 | LMNA (0.59) | CYP3A4CYP2C19L3MBTL1SMN1; SMN2LMNA | |
| SCHEMBL8843492 | 0.80 | ALDH1A1 (0.59) | CYP3A4CYP2C19L3MBTL1SMN1; SMN2LMNA | |
| SCHEMBL4418820 | 0.80 | LMNA (0.51) | CYP3A4CYP2C19L3MBTL1SMN1; SMN2LMNA | |
| SCHEMBL9080 | 0.80 | GAA (0.66) | CYP3A4CYP2C19L3MBTL1SMN1; SMN2LMNA | |
| SCHEMBL24847549 | 0.79 | CYP1A2 (0.54) | CYP3A4CYP2C19SMN1; SMN2LMNACYP1A2 | |
| SCHEMBL1653407 | 0.79 | CYP1A2 (0.54) | CYP3A4CYP2C19SMN1; SMN2LMNACYP1A2 | |
| SCHEMBL8843835 | 0.79 | ALDH1A1 (0.66) | LMNAHDAC3GAAKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004056181-A1 | ORGAN PRECONDITIONING, ARREST, PROTECTION, PRESERVATION AND RECOVERY (2) | GLOBAL CARDIAC SOLUTIONS PTY LTD (AU) | 2004-07-08 | — | — | WO | claimed |
| WO-2004056180-A1 | ORGAN PRECONDITIONING, ARREST, PROTECTION, PRESERVATION AND RECOVERY (1) | GLOBAL CARDIAC SOLUTIONS PTY LTD (AU) | 2004-07-08 | — | — | WO | claimed |
| EP-3021856-B1 | COMPOSITION FOR INDUCING ORGAN ARREST AND PROTECTION, PRESERVATION AND REDUCTION OF TISSUE INJURY | HIBERNATION THERAPEUTICS A KF LLC (US) | 2020-10-07 | — | — | EP | disclosed |
| US-10786525-B2 | Method for treating haemorrhage, shock and brain injury | HIBERNATION THERAPEUTICS A KF LLC (US) | 2020-09-29 | — | — | US | disclosed |
| US-20160271161-A1 | METHOD FOR TREATING HAEMORRHAGE, SHOCK AND BRAIN INJURY | HTS THERAPEUTICS PTY LTD (AU) | 2016-09-22 | — | — | US | disclosed |
| CN-105705151-A | A method for treating hemorrhage, shock and brain injury | 低温药理KF有限公司 | 2016-06-22 | — | — | CN | disclosed |
| US-20160166598-A1 | A METHOD FOR TREATING INFECTION, SEPSIS AND INJURY | HTS THERAPEUTICS PTY LTD (AU) | 2016-06-16 | — | — | US | disclosed |
| US-20160158280-A1 | A METHOD FOR ORGAN ARREST, PROTECTION AND PRESERVATION AND REDUCING TISSUE INJURY | HTS THERAPEUTICS PTY LTD (AU) | 2016-06-09 | — | — | US | disclosed |
| EP-3021854-A1 | A METHOD FOR TREATING INFECTION, SEPSIS AND INJURY | Hibernation Therapeutics, a KF LLC (US) | 2016-05-25 | — | — | EP | disclosed |
| EP-3021855-A1 | A METHOD FOR TREATING HAEMORRHAGE, SHOCK AND BRAIN INJURY | Hibernation Therapeutics, a KF LLC (US) | 2016-05-25 | — | — | EP | disclosed |
| EP-3021856-A1 | A METHOD FOR ORGAN ARREST, PROTECTION AND PRESERVATION AND REDUCING TISSUE INJURY | Hibernation Therapeutics, a KF LLC (US) | 2016-05-25 | — | — | EP | disclosed |
| CN-1738611-A | Alpha-aminoamide derivatives useful as antimigraine agents | NEWRON PHARM SPA (IT) | 2006-02-22 | — | — | CN | disclosed |
| WO-2005102300-A1 | α-AMINOAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF RESTLESS LEGS SYNDROME AND ADDICTIVE DISORDERS | NEWRON PHARMACEUTICALS S.P.A. (IT) | 2005-11-03 | — | — | WO | disclosed |
| EP-1588704-A1 | Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders | Newron Pharmaceuticals S.p.A. (IT) | 2005-10-26 | — | — | EP | disclosed |
| US-20050202394-A1 | Organ arrest, protection, preservation and recovery | GLOBAL CARDIAC SOLUTIONS PTY. LTD. (AU) | 2005-09-15 | — | — | US | disclosed |
| WO-2005070405-A1 | ALPHA-AMINOAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF LOWER URINARY TRACT DISORDERS | NEWRON PHARMACEUTICALS S.P.A. (IT) | 2005-08-04 | — | — | WO | disclosed |
| EP-1557166-A1 | Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders | Newron Pharmaceuticals S.p.A. (IT) | 2005-07-27 | — | — | EP | disclosed |
| WO-2005018627-A1 | ALPHA-AMINOAMIDE DERIVATIVES USEFUL AS ANTI-INFLAMMATORY AGENTS | NEWRON PHARMACEUTICALS, SPA (IT) | 2005-03-03 | — | — | WO | disclosed |
| EP-1438956-A1 | Alpha-aminoamide derivatives useful as antimigraine agents | Newron Pharmaceuticals S.p.A. (IT) | 2004-07-21 | — | — | EP | disclosed |
| US-5672615-A | MATRIX-DEGRADING METALLOPROTEINASE INHIBITORS | NOVARTIS CORPORATION (US) | 1997-09-30 | — | — | US | disclosed |